FT Tech Tonic
The risks and rewards of gene-editing
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy.
Hosted on Acast. See acast.com/privacy for more information.